Physician profile
Andrea E Dunaif
NPI 1063442473
$14,939.85
in general payments reported to CMS, 2019-2025
6 companies · $595 in 2025
The $595 reported for 2025 was more than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $250 · 2021: $1,360 · 2022: $7,686 · 2024: $5,049 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $4,418 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $595 · Travel and Lodging: $546 · Food and Beverage: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $4,417.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $595.00 |
| Travel and Lodging | $546.13 |
| Food and Beverage | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neurocrine Biosciences, INC. | $7,686.48 | 2022 | |
| Merck Sharp & Dohme LLC | $5,048.63 | 2024 | |
| Novo Nordisk Health Care Ag | $1,360.00 | 2021 | |
| Dexcom, INC. | $595.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $124.74 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrea Dunaif listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.